Pharma's Almanac: Nice Insight's Content Community

Articles
Expert Interviews
Roundtable
Press Releases
Videos
Thought Leaders

Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing

AbCellera

Sort By

Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.

Explore

About Us
Nice Insight
That's Nice

Reach Out Team

Contact Us
Advertise

My Account

Login/Sign up

Site

Privacy Policy
Terms And Conditions

© 2024 PHARMA’S ALMANAC. All rights reserved.

1 / 1

1 / 1

What strategies are being employed to accelerate product development and commercialization without compromising quality?

Accelerating Product Development

What strategies are being employed to accelerate product development and commercialization without compromising quality?

Pharma's Almanac

PAO-03-24-CL-02March 08, 2024

AbCellera Expands Technology Stack with Acquisition of Trianni for $90 Million

M&A

AbCellera Expands Technology Stack with Acquisition of Trianni for $90 Million

AbCellera Biologics Inc.

PR-M11-20-018November 19, 2020

AbCellera Announces Therapeutic Antibody Discovery Collaboration with Gilead in Infectious Disease

Announcement

AbCellera Announces Therapeutic Antibody Discovery Collaboration with Gilead in Infectious Disease

AbCellera Biologics Inc.

PR-M06-19-NI-017June 14, 2019